Edwards Lifesciences Corp
EW
Company Profile
Business description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Contact
One Edwards Way
IrvineCA92614
USAT: +1 949 250-2500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
15,800
Stocks News & Analysis
personal-finance
US stock market outlook: tariffs are 2025's wild card
Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,961.70 | 8.20 | -0.10% |
| CAC 40 | 7,335.40 | 62.28 | 0.86% |
| DAX 40 | 21,253.70 | 298.87 | 1.43% |
| Dow JONES (US) | 40,368.96 | 155.83 | -0.38% |
| FTSE 100 | 8,249.12 | 114.78 | 1.41% |
| HKSE | 21,056.72 | 409.55 | -1.91% |
| NASDAQ | 16,823.17 | 8.32 | -0.05% |
| Nikkei 225 | 33,920.40 | 347.14 | -1.01% |
| NZX 50 Index | 12,067.92 | 56.58 | 0.47% |
| S&P 500 | 5,396.63 | 9.34 | -0.17% |
| S&P/ASX 200 | 7,758.90 | 2.80 | -0.04% |
| SSE Composite Index | 3,272.75 | 5.09 | 0.16% |